Literature DB >> 17827014

Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor.

Min Teng1, Michael D Johnson, Christine Thomas, Dan Kiel, James N Lakis, Tim Kercher, Shelley Aytes, Jarek Kostrowicki, Dilip Bhumralkar, Larry Truesdale, John May, Ulla Sidelman, Janos T Kodra, Anker Steen Jørgensen, Preben Houlberg Olesen, Johannes Cornelis de Jong, Peter Madsen, Carsten Behrens, Ingrid Pettersson, Lotte Bjerre Knudsen, Jens J Holst, Jesper Lau.   

Abstract

Following our previous publication describing the biological profiles, we herein describe the structure-activity relationships of a core set of quinoxalines as the hGLP-1 receptor agonists. The most potent and efficacious compounds are 6,7-dichloroquinoxalines bearing an alkyl sulfonyl group at the C-2 position and a secondary alkyl amino group at the C-3 position. These findings serve as a valuable starting point for the discovery of more drug-like small molecule agonists for the hGLP-1 receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827014     DOI: 10.1016/j.bmcl.2007.06.086

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Emilia E Savage; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 2.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery.

Authors:  Ming-wei Wang; Qing Liu; Cai-hong Zhou
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

Review 5.  GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities.

Authors:  Jonathan D Roth; Mary R Erickson; Steve Chen; David G Parkes
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Celine Valant; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2011-05-26       Impact factor: 4.436

7.  Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Celine Valant; Rohan Sridhar; Owen L Woodman; Laurence J Miller; Roger J Summers; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2010-06-14       Impact factor: 4.436

Review 8.  Oral delivery of glucagon-like peptide-1 and analogs: alternatives for diabetes control?

Authors:  Francisca Araújo; Pedro Fonte; Hélder A Santos; Bruno Sarmento
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

9.  Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.

Authors:  Min He; Haoran Su; Weiwei Gao; Stina M Johansson; Qing Liu; Xiaoyan Wu; Jiayu Liao; Andrew A Young; Tamas Bartfai; Ming-Wei Wang
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

10.  A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.

Authors:  Whitney M Nolte; Jean-Philippe Fortin; Benjamin D Stevens; Gary E Aspnes; David A Griffith; Lise R Hoth; Roger B Ruggeri; Alan M Mathiowetz; Chris Limberakis; David Hepworth; Philip A Carpino
Journal:  Nat Chem Biol       Date:  2014-07-06       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.